These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17401745)

  • 1. The effect of levetiracetam in startle disease.
    Luef GJ; Löscher WN
    J Neurol; 2007 Jun; 254(6):808-9. PubMed ID: 17401745
    [No Abstract]   [Full Text] [Related]  

  • 2. Repeated use of subcutaneous levetiracetam in a palliative care patient.
    López-Saca JM; Vaquero J; Larumbe A; Urdíroz J; Centeno C
    J Pain Symptom Manage; 2013 May; 45(5):e7-8. PubMed ID: 23535323
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M; Pong AW
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of levetiracetam on hippocampal kindling in Noda epileptic rats.
    Ishimaru Y; Chiba S; Serikawa T; Sasa M; Inaba H; Tamura Y; Ishimoto T; Takasaki H; Sakamoto K; Yamaguchi K
    Brain Res; 2010 Jan; 1309():104-9. PubMed ID: 19879253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
    Sethi NK; Torgovnick J; Arsura E
    Neurology; 2007 Aug; 69(9):937; author reply 937-8. PubMed ID: 17724302
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of levetiracetam on essential tremor.
    Bushara KO; Malik T; Exconde RE
    Neurology; 2005 Mar; 64(6):1078-80. PubMed ID: 15781835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT interval prolongation in a patient with LQT2 on levetiracetam.
    Issa NP; Fisher WG; Narayanan JT
    Seizure; 2015 Jul; 29():134-6. PubMed ID: 26076856
    [No Abstract]   [Full Text] [Related]  

  • 8. [Levetiracetam (keppra) in the treatment of different epileptic syndromes in adults].
    Rudakova IG; Kotov AS; Kotov SV; Belova IuA; Lavrent'eva NS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):25-9. PubMed ID: 20037566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent levetiracetam treatment in five patients with catamenial epilepsy.
    Liu J; Yu N; Sun H; Liang Y; Xie Y; Chen K
    J Pak Med Assoc; 2015 Jul; 65(7):793-5. PubMed ID: 26160095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spritam--a new formulation of levetiracetam for epilepsy.
    Med Lett Drugs Ther; 2016 Jun; 58(1497):78-9. PubMed ID: 27305068
    [No Abstract]   [Full Text] [Related]  

  • 11. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.
    Betts T; Waegemans T; Crawford P
    Seizure; 2000 Mar; 9(2):80-7. PubMed ID: 10845730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam in pediatrics.
    Vigevano F
    J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study of the use of levetiracetam in childhood seizure disorders.
    Koukkari MW; Guarino EJ
    J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.
    Kang BS; Moon HJ; Kim YS; Lee ST; Jung KH; Chu K; Lee SK
    Epileptic Disord; 2013 Sep; 15(3):302-10. PubMed ID: 23981665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.
    Genton P; Sadzot B; Fejerman N; Peltola J; Despland PA; Steinhoff B; Rektor I; Wroe S; Maubrey MC; Vandervelden C; van Hammée G; Schlit AF; van Paesschen W
    Acta Neurol Scand; 2006 Jun; 113(6):387-94. PubMed ID: 16674605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of infantile spasms to levetiracetam.
    Mikati MA; El Banna D; Sinno D; Mroueh S
    Neurology; 2008 Feb; 70(7):574-5. PubMed ID: 18268250
    [No Abstract]   [Full Text] [Related]  

  • 18. Startle disease--hyperekplexia (two sibling cases).
    Altunbaşak S; Baytok V
    Seizure; 1996 Dec; 5(4):313-5. PubMed ID: 8952019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam: a long-term follow-up study of efficacy and safety.
    Bauer J; Ben-Menachem E; Krämer G; Fryze W; Da Silva S; Kasteleijn-Nolst Trenité DG
    Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam associated acute hepatic failure requiring liver transplantation: case report.
    Selvaraj V; Madabushi JS; Gunasekar P; Singh SP
    J Neurol; 2016 Apr; 263(4):814-5. PubMed ID: 26902232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.